(Q33983920)

30 July 2017

1 reference

title

Adverse reactions to new anticonvulsant drugs (English)

1 reference

30 July 2017

I C Wong

1

1 reference

30 July 2017

S D Lhatoo

series ordinal

2

1 reference

30 July 2017

publication date

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

35-56

1 reference

Care of adults with epilepsy in the United States

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Visual field defect associated with vigabatrin: observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200023010-00003

Gabapentin associated with aggressive behavior in pediatric patients with seizures

21 January 2018

1 reference

12 December 2020

Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk

1 reference

12 December 2020

Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?

1 reference

12 December 2020

Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group

1 reference

12 December 2020

Safety of topiramate: adverse events and relationships to dosing

1 reference

12 December 2020

Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial

1 reference

12 December 2020

Treatment of epilepsy in pregnancy

1 reference

12 December 2020

Vigabatrin in the treatment of epilepsy in children

1 reference

12 December 2020

Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.

1 reference

12 December 2020

Aggravation of focal epileptic seizures by antiepileptic drugs

1 reference

12 December 2020

Tiagabine monotherapy in the treatment of partial epilepsy

1 reference

12 December 2020

The neuropathology of vigabatrin

1 reference

12 December 2020

A neuropharmacological evaluation of felbamate as a novel anticonvulsant

1 reference

12 December 2020

Anemia associated with lamotrigine

1 reference

12 December 2020

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

1 reference

12 December 2020

1 reference

12 December 2020

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

12 December 2020

Hypomania induced by gabapentin

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin

1 reference

12 December 2020

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

1 reference

12 December 2020

Retrospective study of vigabatrin and psychiatric behavioural disturbances.

1 reference

12 December 2020

Oxcarbazepine-induced hyponatremia, a cross-sectional study

1 reference

12 December 2020

The occurrence of drug-induced myopia as a transient side effect of topiramate

1 reference

12 December 2020

Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons

1 reference

12 December 2020

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

12 December 2020

An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels

1 reference

12 December 2020

Multisystem adverse reaction to lamotrigine

1 reference

12 December 2020

Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis

1 reference

12 December 2020

Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management

1 reference

12 December 2020

Clinical and EEG findings in complex partial status epilepticus with tiagabine

1 reference

12 December 2020

Epilepsy with myoclonic absences

1 reference

12 December 2020

Vigabatrin in childhood epilepsy.

1 reference

12 December 2020

The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin

1 reference

12 December 2020

Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation

1 reference

12 December 2020

Lamotrigine versus carbamazepine in epilepsy

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

12 December 2020

IgA and IgG2 deficiency associated with zonisamide therapy: a case report

1 reference

12 December 2020

Safety of lamotrigine

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent

1 reference

12 December 2020

Therapeutic trial of vigabatrin in refractory infantile spasms

1 reference

12 December 2020

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

1 reference

12 December 2020

Double-blind study of Gabapentin in the treatment of partial seizures

1 reference

12 December 2020

Vigabatrin and behaviour disorders: a retrospective survey.

1 reference

12 December 2020

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

1 reference

12 December 2020

Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma

1 reference

12 December 2020

Allergic vasculitis caused by Vigabatrin

1 reference

12 December 2020

Hyponatraemia during oxcarbazepine therapy

1 reference

12 December 2020

Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy

1 reference

12 December 2020

Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy

1 reference

12 December 2020

Anticonvulsant drugs and mental symptoms: a review

1 reference

12 December 2020

Reversibility of vigabratin-induced visual-field defect

1 reference

12 December 2020

1 reference

12 December 2020

Nonconvulsive status epilepticus in two patients receiving tiagabine treatment

1 reference

12 December 2020

Bipolar affective psychosis after vigabatrin

1 reference

12 December 2020

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

1 reference

12 December 2020

Tiagabine and non-convulsive status epilepticus

1 reference

12 December 2020

Antiepileptic drug-induced worsening of seizures in children

1 reference

12 December 2020

The Long-Term Use of Gabapentin, Lamotrigine, and Vigabatrin in Patients with Chronic Epilepsy

1 reference

12 December 2020

Efficacy and safety of zonisamide: results of a multicenter study.

1 reference

12 December 2020

Acute encephalopathy associated with vigabatrin monotherapy in patients with mild renal failure

1 reference

12 December 2020

Taming the brain storms: felbamate updated

1 reference

12 December 2020

Behavioral side effects of gabapentin in children.

1 reference

12 December 2020

Neuropsychological effects of tiagabine, a potential new antiepileptic drug.

1 reference

12 December 2020

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

12 December 2020

Disabling tremor after lamotrigine with sodium valproate

1 reference

12 December 2020

Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients

1 reference

12 December 2020

Zonisamide: a new antiepileptic drug.

1 reference

12 December 2020

Leucopenia associated with lamotrigine

1 reference

12 December 2020

Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy

1 reference

12 December 2020

Felbamate in epilepsy therapy: evaluating the risks

1 reference

12 December 2020

Two cases of nonconvulsive status epilepticus in association with tiagabine therapy

1 reference

12 December 2020

Self-poisoning with lamotrigine

1 reference

12 December 2020

The new anticonvulsant drugs. Implications for avoidance of adverse effects

1 reference

12 December 2020

Lack of serious toxicity following gabapentin overdose

1 reference

12 December 2020

?-Vinyl GABA: comparison of neurochemical and anticonvulsant effects in mice

1 reference

12 December 2020

Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects

1 reference

12 December 2020

Fulminant hepatic failure induced by lamotrigine

1 reference

12 December 2020

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action

1 reference

12 December 2020

Cross-reactive skin eruption with both carbamazepine and oxcarbazepine

1 reference

12 December 2020

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

12 December 2020

Safety review of adult clinical trial experience with lamotrigine

1 reference

12 December 2020

Lamotrigine and toxic epidermal necrolysis

1 reference

12 December 2020

Effects of zonisamide on dopaminergic system

1 reference

12 December 2020

Acute encephalopathy with vigabatrin

1 reference

12 December 2020

Fatal toxic epidermal necrolysis related to lamotrigine administration

1 reference

12 December 2020

A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma

1 reference

12 December 2020

Factors Influencing the Incidence of Lamotrigine-Related Skin Rash

1 reference

12 December 2020

Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: an electroencephalographic study

1 reference

12 December 2020

Gamma-vinyl GABA (vigabatrin) and mood disturbances

1 reference

12 December 2020

Drug-induced pseudolymphoma secondary to lamotrigine

1 reference

12 December 2020

Two Cases with Epilepsy Who Manifested Manic-Depressive Symptoms under Barbiturates Treatment

1 reference

12 December 2020

Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin

1 reference

12 December 2020

Toxic epidermal necrolysis after treatment with lamotrigine (Lamictal)

1 reference

12 December 2020

Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment

1 reference

12 December 2020

Lamotrigine and toxic epidermal necrolysis

1 reference

12 December 2020

Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures

1 reference

12 December 2020

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

12 December 2020

Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture

1 reference

12 December 2020

Methodological requirements for clinical trials in refractory epilepsies--our experience with zonisamide

1 reference

12 December 2020

Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine

1 reference

12 December 2020

Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control

1 reference

12 December 2020

Repeated administration of gamma-vinylGABA reduces rat brain glutamine synthetase activity

1 reference

12 December 2020

Gabapentin toxicity in children manifesting as behavioral changes.

1 reference

12 December 2020

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

12 December 2020

Phenobarbital exacerbation of self-injurious behavior

1 reference

12 December 2020

Lamotrigine and toxic epidermal necrolysis.

1 reference

12 December 2020

Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum

1 reference

12 December 2020

Acute encephalopathy with vigabatrin

1 reference

12 December 2020

Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures.

1 reference

12 December 2020

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

1 reference

12 December 2020

Guidelines for the rational use of benzodiazepines. When and what to use.

1 reference

12 December 2020

Topiramate and fulminant liver failure

1 reference

12 December 2020

Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide

1 reference

12 December 2020

Vigabatrin and behaviour disturbance

1 reference

12 December 2020

Movement disorders associated with the use of gabapentin

1 reference

12 December 2020

New antiepileptic drugs in children: present and future

1 reference

12 December 2020

Acute psychosis after withdrawal of vigabatrin

1 reference

12 December 2020

Aggravation of generalized epilepsies

1 reference

12 December 2020

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

12 December 2020

Vigabatrin and behaviour disturbances.

1 reference

12 December 2020

Zonisamide-induced behavior disorder in two children.

1 reference

12 December 2020

gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy

1 reference

12 December 2020

Practical aspects of oxcarbazepine treatment.

1 reference

12 December 2020

Deliberate overdose with the novel anticonvulsant tiagabine

1 reference

12 December 2020

Lamotrigine encephalopathy

1 reference

12 December 2020

Subsequent manic disorder due to combination vigabatrin-clomipramine

1 reference

12 December 2020

An Audit of the Perceived Efficacy and Tolerability of Gabapentin Therapy in an Out-Patient Cohort with Chronic Epilepsy

1 reference

12 December 2020

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

12 December 2020

Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.

1 reference

12 December 2020

Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid

1 reference

12 December 2020

Rapid aggravation of aphasia by vigabatrin

1 reference

12 December 2020

Vigabatrin and depression

1 reference

12 December 2020

Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies

1 reference

12 December 2020

Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor

1 reference

12 December 2020

Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?

1 reference

12 December 2020

Gabapentin induced polyneuropathy

1 reference

12 December 2020

Tiagabine: The Safety Landscape

1 reference

12 December 2020

Suspected lamotrigine-induced toxic epidermal necrolysis

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin

1 reference

12 December 2020

Vigabatrin and complex partial status

1 reference

12 December 2020

Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds

1 reference

12 December 2020

Antiepileptic drugs as a cause of worsening seizures

1 reference

12 December 2020

Hyponatremic coma under oxcarbazepine therapy

1 reference

12 December 2020

Psychomotor agitation following gabapentin use in brain injury

1 reference

12 December 2020

Choreoathetotic movements: A possible side effect of gabapentin.

1 reference

12 December 2020

Lamotrigine as an add-on drug in typical absence seizures

1 reference

12 December 2020

Complex partial status after starting vigabatrin

1 reference

12 December 2020

Gabapentin in partial epilepsy. UK Gabapentin Study Group

1 reference

12 December 2020

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

12 December 2020

Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy

1 reference

12 December 2020

Tiagabine-induced absence status in idiopathic generalized epilepsy

1 reference

12 December 2020

Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy

1 reference

12 December 2020

Reversible motor disturbances induced by vigabatrin

1 reference

12 December 2020

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

1 reference

12 December 2020

Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

1 reference

12 December 2020

10.2165/00002018-200023010-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1012416797

0 references

1 reference